A study by Schröder et al. demonstrated that pharmacological targeting of Trx1 using dimethyl fumarate induces ripoptosome-mediated cell death in malignant T cells, highlighting Trx1 as a redox-sensitive vulnerability in cancer [134]. Here, TXN is linked to cancer.